C

Currus Biologics Pty Ltd

5 employees

Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$7.5M

from 1 investors over 1 rounds

C

Currus Biologics Pty Ltd raised $7.5M on June 29, 2021

Investors: Uniseed

FAQ